Krystal Biotech, Inc. Quarterly Current Ratio in % from Q2 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Krystal Biotech, Inc. quarterly Current Ratio history and growth rate from Q2 2018 to Q3 2024.
  • Krystal Biotech, Inc. Current Ratio for the quarter ending September 30, 2024 was 1.07K %, a 31.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 1.07K -496 -31.7% Sep 30, 2024
Q2 2024 1.36K -36 -2.57% Jun 30, 2024
Q1 2024 1.71K +468 +37.8% Mar 31, 2024
Q4 2023 1.68K +593 +54.6% Dec 31, 2023
Q3 2023 1.56K +416 +36.2% Sep 30, 2023
Q2 2023 1.4K +341 +32.2% Jun 30, 2023
Q1 2023 1.24K +99.3 +8.72% Mar 31, 2023
Q4 2022 1.09K -675 -38.3% Dec 31, 2022
Q3 2022 1.15K -631 -35.5% Sep 30, 2022
Q2 2022 1.06K -1.62K -60.5% Jun 30, 2022
Q1 2022 1.14K -2.23K -66.2% Mar 31, 2022
Q4 2021 1.76K -1.46K -45.4% Dec 31, 2021
Q3 2021 1.78K -2.97K -62.6% Sep 30, 2021
Q2 2021 2.68K -2.55K -48.8% Jun 30, 2021
Q1 2021 3.37K -1.85K -35.4% Mar 31, 2021
Q4 2020 3.23K -1.72K -34.8% Dec 31, 2020
Q3 2020 4.75K +153 +3.32% Sep 30, 2020
Q2 2020 5.24K +1.22K +30.4% Jun 30, 2020
Q1 2020 5.21K +1.47K +39.1% Mar 31, 2020
Q4 2019 4.95K +425 +9.41% Dec 31, 2019
Q3 2019 4.6K -606 -11.6% Sep 30, 2019
Q2 2019 4.02K -513 -11.3% Jun 30, 2019
Q1 2019 3.75K Mar 31, 2019
Q4 2018 4.52K Dec 31, 2018
Q3 2018 5.21K Sep 30, 2018
Q2 2018 4.53K Jun 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.